288 related articles for article (PubMed ID: 19027789)
1. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development.
Duan RD; Nilsson A
Prog Lipid Res; 2009 Jan; 48(1):62-72. PubMed ID: 19027789
[TBL] [Abstract][Full Text] [Related]
2. [Role of sphingolipids in digestive system].
Kurek K; Piotrowska DM; Wiesiołek P; Chabowski A; Zendzian-Piotrowska M
Postepy Hig Med Dosw (Online); 2012 Nov; 66():868-75. PubMed ID: 23175343
[TBL] [Abstract][Full Text] [Related]
3. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy.
Huwiler A; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2007 Aug; 63(2):150-9. PubMed ID: 17560117
[TBL] [Abstract][Full Text] [Related]
4. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
5. Physiological functions and clinical implications of sphingolipids in the gut.
Duan RD
J Dig Dis; 2011 Apr; 12(2):60-70. PubMed ID: 21401891
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
7. Anticancer compounds and sphingolipid metabolism in the colon.
Duan RD
In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
[TBL] [Abstract][Full Text] [Related]
8. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
9. Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.
Kurek K; Łukaszuk B; Piotrowska DM; Wiesiołek P; Chabowska AM; Zendzian-Piotrowska M
Biomed Res Int; 2013; 2013():908907. PubMed ID: 24083248
[TBL] [Abstract][Full Text] [Related]
10. Measurement of ceramide and sphingolipid metabolism in tumors: potential modulation of chemotherapy.
Modrak DE
Methods Mol Med; 2005; 111():183-94. PubMed ID: 15911980
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?
Singh IN; Hall ED
J Neurosci Res; 2008 May; 86(7):1419-33. PubMed ID: 18058948
[TBL] [Abstract][Full Text] [Related]
12. Ceramide and other sphingolipids in cellular responses.
Yang J; Yu Y; Sun S; Duerksen-Hughes PJ
Cell Biochem Biophys; 2004; 40(3):323-50. PubMed ID: 15211031
[TBL] [Abstract][Full Text] [Related]
13. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipids in cancer: regulation of pathogenesis and therapy.
Ogretmen B
FEBS Lett; 2006 Oct; 580(23):5467-76. PubMed ID: 16970943
[TBL] [Abstract][Full Text] [Related]
15. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease.
Wollny T; Wątek M; Durnaś B; Niemirowicz K; Piktel E; Żendzian-Piotrowska M; Góźdź S; Bucki R
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362332
[TBL] [Abstract][Full Text] [Related]
17. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.
Blandizzi C
Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
19. Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites.
Duan RD; Cheng Y; Jönsson BA; Ohlsson L; Herbst A; Hellström-Westas L; Nilsson A
Pediatr Res; 2007 Jan; 61(1):61-6. PubMed ID: 17211142
[TBL] [Abstract][Full Text] [Related]
20. Beyond a structural component: sphingolipids in immunology.
Prieschl EE; Baumruker T
Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]